ÂÜÀòÂÒÂ×

The Investor Relations team at Memo Therapeutics is dedicated to fostering strong relationships with current and potential investors, ensuring transparent communication about the company's strategic direction, financial performance, and advancements in antibody discovery. This team plays a critical role in building investor confidence and providing insights into the innovative efforts of Memo Therapeutics in immune repertoire analysis.